Image

Arterial Spin Label Depicted Ischemic Stroke Cohort (ASLIS)

Recruiting
30 - 90 years of age
Both
Phase N/A

Powered by AI

Overview

Establish a clinical cohort of acute ischemic stroke patients and find the determinant of the prognosis.

Description

  1. Enrollment: screening the candidates based on the inclusion and exclusion criteria, and sign the informed consent.
  2. Baseline evaluation: evaluate baseline situation of enrolled candidates.
  3. Inpatient view: view and evaluate enrolled candidates respectively at day 1, 3, 7 and 14 after stroke, and record the results.
  4. Follow-up: view the candidates at 90 days and one year after stroke onset, and record the results.
  5. Data analysis: analyze the results.

Eligibility

Inclusion Criteria:

  1. Age 30-90, no gender restrictions.
  2. Onset of disease ≤7 days.
  3. Meet either of the following two conditions:

    ① Transient ischemic attack (TIA)

    ② Ischemia stroke (IS) Note: Acute IS diagnosis criteria: sudden and persistent focal or widespread neurological dysfunction, excluding other non-vascular causes of brain dysfunction (such as brain infection, head injury, brain tumor, epilepsy, severe metabolic diseases, or degenerative neurological diseases), confirmed by image as new IS. TIA diagnosis criteria: sudden and reversible focal neurological or retinal ischemic deficit caused by a reversible ischemia, usually lasting less than 24 hours, with no evidence of new IS on imaging, and excluding other non-ischemic causes (such as brain infection, head injury, brain tumor, epilepsy, severe metabolic diseases, or degenerative neurological diseases).

  4. Signed informed consent

Exclusion Criteria:

  1. Clear cause of ischemic stroke other than atrial fibrillation.
  2. Other ischemic strokes with a clear cause.
  3. Presence of non-vascular intracranial disease.
  4. Presence of severe systemic diseases.
  5. Pregnancy or lactation.
  6. Unable to tolerate or cooperate with MRI examination.
  7. Unable to comply with follow-up due to geographical or other reasons.

Study details

Acute Ischemic Stroke

NCT05920902

Ruijin Hospital

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.